BACKGROUND: Advances in the treatment of anorexia nervosa (AN) are most likely to arise from targeted, brain-directed treatments, such as repetitive transcranial magnetic stimulation (rTMS). We describe findings from two individuals with treatment-resistant AN who received 19-20 sessions of neuronavigated, high frequency rTMS, applied to the left dorsolateral prefrontal cortex. METHOD: Within-session measures assessed changes pre-rTMS, post-rTMS in subjective eating disorder (ED) experiences. Weight, ED symptoms and mood were assessed pre-treatment, post-treatment and at 1 month follow-up. RESULTS: In both cases, there was improvement in ED symptomatology and mood after 19-20 sessions of neuronavigated rTMS, and these changes persisted or continued to improve at follow-up. Within sessions, Patient A demonstrated a consistent reduction in subjective ED experiences, and Patient B a reduction in some ED related experiences. CONCLUSIONS: These findings suggest that rTMS has potential as an adjunct to the treatment of AN and deserves further study.
BACKGROUND: Advances in the treatment of anorexia nervosa (AN) are most likely to arise from targeted, brain-directed treatments, such as repetitive transcranial magnetic stimulation (rTMS). We describe findings from two individuals with treatment-resistant AN who received 19-20 sessions of neuronavigated, high frequency rTMS, applied to the left dorsolateral prefrontal cortex. METHOD: Within-session measures assessed changes pre-rTMS, post-rTMS in subjective eating disorder (ED) experiences. Weight, ED symptoms and mood were assessed pre-treatment, post-treatment and at 1 month follow-up. RESULTS: In both cases, there was improvement in ED symptomatology and mood after 19-20 sessions of neuronavigated rTMS, and these changes persisted or continued to improve at follow-up. Within sessions, Patient A demonstrated a consistent reduction in subjective ED experiences, and Patient B a reduction in some ED related experiences. CONCLUSIONS: These findings suggest that rTMS has potential as an adjunct to the treatment of AN and deserves further study.
Authors: D Val-Laillet; E Aarts; B Weber; M Ferrari; V Quaresima; L E Stoeckel; M Alonso-Alonso; M Audette; C H Malbert; E Stice Journal: Neuroimage Clin Date: 2015-03-24 Impact factor: 4.881
Authors: Alexandra F Muratore; Mariya Bershad; Joanna E Steinglass; Karin E Foerde; Loren Gianini; Allegra Broft; Evelyn Attia Journal: Int J Eat Disord Date: 2021-08-20 Impact factor: 5.791
Authors: Jessica McClelland; Maria Kekic; Natali Bozhilova; Steffen Nestler; Tracy Dew; Frederique Van den Eynde; Anthony S David; Katya Rubia; Iain C Campbell; Ulrike Schmidt Journal: PLoS One Date: 2016-03-23 Impact factor: 3.240
Authors: Bethan Dalton; Savani Bartholdy; Jessica McClelland; Maria Kekic; Samantha J Rennalls; Jessica Werthmann; Ben Carter; Owen G O'Daly; Iain C Campbell; Anthony S David; Danielle Glennon; Nikola Kern; Ulrike Schmidt Journal: BMJ Open Date: 2018-07-16 Impact factor: 2.692